Read More

NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What’s Behind The Surge?

The Canadian cannabis sector is witnessing a notable upswing, driven by recent developments including Tilray's (NASDAQ: TLRY) earnings report, Organigram's investor day (NASDAQ: OGI) and pivotal movements by Canopy Growth (NASDAQ:

ACB

Read More

Johnson & Johnson’s Carvykti Stands Ahead Of Bristol Myers’ Rival Blood Cancer Therapy With FDA Approval For Wider Population

FDA approves Johnson & Johnson's Carvykti, a BCMA-targeted therapy for relapsed or refractory multiple myeloma patients, offering hope with increased manufacturing capacity and extended collaboration efforts.

JNJ